Evidence map›Paper›PMID 39129309›Full record

ReviewInternational journal of qualitative studies on health and well-being2024

From unwelcome to supportive. Patients' conceptions of being prescribed a glucose-lowering drug at type 2 diabetes diagnosis - a phenomenographic study.

Sofia Dalemo, Yvonne Carlsson, Johan Alsterhag, Susanne Andersson

Abstract readReview
In one paragraph

Review in International journal of qualitative studies on health and well-being, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sofia DalemoFoU-Centrum Skaraborg - R&D Centre Skaraborg, Skövde, Sweden.ORCID 0000-0003-1060-3676
Yvonne CarlssonGeneral Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0001-8317-488X
Johan AlsterhagFoU-Centrum Skaraborg - R&D Centre Skaraborg, Skövde, Sweden.
Susanne AnderssonFoU-Centrum Skaraborg - R&D Centre Skaraborg, Skövde, Sweden.ORCID 0000-0002-2188-4306

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGuidelines recommend starting glucose-lowering drug upon type 2 diabetes mellitus diagnosis together with lifestyle changes. Lifestyle changes are as essential as the drug, earlier recommendations allowed some months of lifestyle changes while being drug-free. Prescription on diagnosis may interfere with patients' understanding and motivation for lifestyle changes if they cannot evaluate the effect on blood glucose.

methodsA phenomenographic approach and interviews were conducted with patients who started a glucose-lowering drug at diagnosis.

resultsThree qualitatively different conceptions of being prescribed glucose-lowering drugs in connection to type 2 diabetes mellitus diagnosis were found: "Drugs as something unwelcome," "Drugs as a support," and "Drugs as a means to reach the goal". These conceptions range broadly from drugs as unwelcome to drugs as a support for lifestyle changes and an opportunity to influence the course of the lifelong disease to reach a goal.

conclusionsThis study has identified various perspectives of patients' understanding of the role of lifestyle changes in managing their disease. The patients undergo a process, and the perspectives vary, providing a more extensive and nuanced understanding. It is, therefore, impossible to apply a routine protocol and a person-centred approach is required when prescribing a glucose-lowering drug.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsLife StyleAdultAgedBlood GlucoseFemaleHumansMaleMiddle AgedMotivationQualitative ResearchBlood GlucoseHypoglycemic AgentsDiabetes mellitus type 2drug therapylifestylemetforminphenomenographyprimary healthcarequalitative research

Identifiers

PMID39129309
PMCPMC11321111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.